Skip to main content
. 2024 Jun 3;14:1386381. doi: 10.3389/fonc.2024.1386381

Figure 4.

Figure 4

Forest plot of ORR in sensitivity analysis excluding patients who received combined immunotherapy and targeted therapy as subsequent-line treatments. (A) 1% cutoff; (B) 10% cutoff; (C) 25% cutoff.